Department of Pharmacy, College of Pharmacy, Chosun University, Gwangju 61452, Republic of Korea.
Department of Pharmacy, College of Pharmacy, Mokpo National University, Muan 58554, Republic of Korea.
Int J Mol Sci. 2024 Jun 27;25(13):7046. doi: 10.3390/ijms25137046.
Global public health is facing a major issue with emerging resistance to antimicrobial agents. Antimicrobial agents that are currently on the market are strong and efficient, but it has not been ruled out that these medications will eventually cause resistance to bacteria. Exploring novel bioactive compounds derived from natural sources is therefore, crucial to meet future demands. The present study evaluated the mode of action of the antimicrobial potential protease enzyme SH21. Protease SH21 exhibited antimicrobial activity, strong heat stability (up to 100 °C), and pH stability (pH 3.0 to 9.0). In terms of mode of action, we found that protease SH21 was able to disrupt the bacterial cell membrane as the results of the nucleotide leakage and cell membrane permeability assay. In addition, we also checked inner membrane permeability by PI uptake assay which suggested that protease SH21 has the ability to enter the bacterial cell membrane. Our results revealed that the antimicrobial protease SH21 might be a promising candidate for treating microbial infections.
全球公共卫生正面临着一个主要问题,即出现了对抗生素的耐药性。目前市场上的抗生素虽然强大且高效,但不能排除这些药物最终会使细菌产生耐药性。因此,探索源自天然来源的新型生物活性化合物对于满足未来的需求至关重要。本研究评估了抗菌潜在蛋白酶 SH21 的作用模式。蛋白酶 SH21 表现出抗菌活性、强热稳定性(高达 100°C)和 pH 稳定性(pH 值 3.0 至 9.0)。就作用模式而言,我们发现蛋白酶 SH21 能够破坏细菌细胞膜,这是核苷酸泄漏和细胞膜通透性测定的结果。此外,我们还通过 PI 摄取测定检查了内膜通透性,这表明蛋白酶 SH21 具有穿透细菌细胞膜的能力。我们的研究结果表明,抗菌蛋白酶 SH21 可能是治疗微生物感染的一种有前途的候选药物。